Related Experiment Video
Updated: May 18, 2026

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
Published on: November 17, 2020
Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the
Catherine Larochelle1, Romain Cayrol, Hania Kebir
1Neuroimmunology Research Laboratory, Centre of Excellence in Neuromics, Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, Québec, H2L 2W5, Canada.
Insights
Melanoma cell adhesion molecule (MCAM) is found on T cells that drive multiple sclerosis. Blocking MCAM reduces neuroinflammation and disease severity, suggesting MCAM as a therapeutic target.
Area of Science:
- Neuroimmunology
- Cellular and Molecular Immunology
Background:
- Encephalitogenic CD4(+) lymphocytes use adhesion molecules to infiltrate the central nervous system in multiple sclerosis.
- Melanoma cell adhesion molecule (MCAM) expression was identified on human effector memory CD4(+) lymphocytes and blood-brain barrier endothelium.
Purpose of the Study:
- To investigate the role of MCAM in T cell migration and its potential as a biomarker and therapeutic target in multiple sclerosis.
Main Methods:
- Proteomic techniques to identify MCAM expression.
- Flow cytometry to characterize MCAM(+) CD4(+) T lymphocytes.
- In vivo studies using experimental autoimmune encephalomyelitis (EAE) models.
- In vitro assays to assess T cell migration across blood-brain barrier endothelium.
Main Results:
- MCAM is a stable surface marker identifying specific subsets of memory CD4(+) T lymphocytes (interleukin-17+, interleukin-22+, RAR-related orphan receptor γ+, interleukin-23 receptor+).
- MCAM(+) lymphocytes exhibit higher expression of granulocyte/macrophase colony-stimulating factor and granzyme B.
- Increased proportion of MCAM(+) CD4(+) lymphocytes in multiple sclerosis patients and EAE animals; MCAM is upregulated at the blood-brain barrier in lesions.
- MCAM blockade or MCAM(+) CD4(+) T cell depletion reduced T(H)17 cell migration and EAE severity.
Conclusions:
- MCAM is a potential biomarker for multiple sclerosis.
- MCAM represents a promising therapeutic target for neuroinflammatory conditions.
- Targeting MCAM may inhibit T cell infiltration into the central nervous system and ameliorate disease.
Abstract:
In multiple sclerosis, encephalitogenic CD4(+) lymphocytes require adhesion molecules to accumulate into central nervous system inflammatory lesions. Using proteomic techniques, we identified expression of melanoma cell adhesion molecule (MCAM) on a subset of human effector memory CD4(+) lymphocytes and on human blood-brain barrier endothelium. Herein, we demonstrate that MCAM is a stable surface marker that refines the identification of interleukin 17(+), interleukin 22(+), RAR-related orphan receptor γ and interleukin 23 receptor(+) cells within the CD161(+)CCR6(+) subset of memory CD4(+) lymphocytes. We also show that MCAM(+) lymphocytes express significantly more granulocyte/macrophage colony stimulating factor and granzyme B than MCAM(-) lymphocytes. Furthermore, the proportion of MCAM(+) CD4(+) lymphocytes is significantly increased in the blood and in the central nervous system of patients with multiple sclerosis and experimental autoimmune encephalomyelitis animals compared with healthy controls or other neurological diseases, and MCAM expression is upregulated at the blood-brain barrier within inflammatory lesions. Moreover, blockade of MCAM or depletion of MCAM(+) CD4(+) T lymphocytes both restrict the migration of T(H)17 lymphocytes across blood-brain barrier endothelial cells and decrease the severity of experimental autoimmune encephalomyelitis. Our findings indicate that MCAM could serve as a potential biomarker for multiple sclerosis and represents a valuable target for the treatment of neuroinflammatory conditions.
Related Concept Videos
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Selectins
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
The Tumor Microenvironment
